Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.59 |
| ▸ | F2 | P00734 | 4/20 | 0.59 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.55 |
| ▸ | NPY2R | P49146 | 2/20 | 0.55 |
| ▸ | NPY4R | P50391 | 2/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.55 |
| ▸ | EP300 | Q09472 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | TFPI | P10646 | 1/20 | 0.54 |
| ▸ | KDM1A | O60341 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30432355 | 0.93 | CALCR (0.65) | CALCRF2HCRTR1HCRTR2NPY2R | |
| SCHEMBL19003817 | 0.89 | NTSR1 (0.63) | F2NTSR1NTSR2NPY2RNPY4R | |
| SCHEMBL30262137 | 0.89 | NTSR1 (0.58) | CALCRF2NTSR1NTSR2 | |
| SCHEMBL29509548 | 0.89 | TFPI (0.65) | CALCRF2NPY2RNPY4RNPY5R | |
| SCHEMBL31199057 | 0.88 | NPY2R (0.60) | CALCRF2NTSR1NTSR2HCRTR1 | |
| SCHEMBL30831411 | 0.88 | CALCR (0.63) | CALCRF2HCRTR1HCRTR2NPY2R | |
| SCHEMBL29377200 | 0.87 | NTSR1 (0.61) | F2NTSR1NTSR2NPY2RNPY4R | |
| SCHEMBL29420255 | 0.87 | NTSR1 (0.61) | CALCRF2NTSR1NTSR2NPY2R | |
| SCHEMBL30712883 | 0.87 | CALCR (0.62) | CALCRF2TFPIKDM1A | |
| SCHEMBL29420253 | 0.87 | NTSR1 (0.61) | NTSR1NTSR2NPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |